Company · CIK 1641281
Bolt Biotherapeutics, Inc.
| CIK | 1641281 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BOLT (Nasdaq) |
| First annual or quarterly report | 2021-03-31 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263994 | 2022-03-30 | 2022-04-07 | 3 | |
| 333-252136 | 2021-01-15 | 2021-02-05 | 5 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-04-07 | EFFECTDeclared effective | 333-263994 | 9999999995-22-000871 |
| 2022-04-07 | 424B5Shelf takedown | 333-263994 | 0001193125-22-099012 |
| 2022-03-30 | S-3Shelf registered | 333-263994 | 0001193125-22-090029 |
| 2021-02-05 | 424B4Final prospectus | 333-252136 | 0001193125-21-030767 |
| 2021-02-04 | EFFECTDeclared effective | 333-252136 | 9999999995-21-000441 |
| 2021-02-03 | S-1/AAmendment | 333-252136 | 0001193125-21-027469 |
| 2021-02-01 | S-1/AAmendment | 333-252136 | 0001193125-21-023574 |
| 2021-01-15 | S-1Registration filed | 333-252136 | 0001193125-21-010049 |
| 2020-08-10 | DRSDraft made public | 377-03397 | 0000950123-20-008057 |